TORONTO, March 13, 2023--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI; NASDAQ: OGI), announced that it has received notification from Health Canada that Health Canada has determined that certain Jolts lozenge products in their 100 mg THC per package format (the "Products") have been improperly classified as an "extract" rather than an "edible" under the Cannabis Regulations. The Company launched the Products in August 2021 following significant research, development and reg
Investors in cannabis companies should know they're playing a long game. The multi-state operator (MSO) has seen its shares drop 35% over the past year, and that fall has continued with a 9% decline so far in 2023.
TORONTO, March 01, 2023--Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders held on February 28, 2023 (the "Meeting").